Next Article in Journal
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma
Next Article in Special Issue
Unraveling the Role of Guanylate-Binding Proteins (GBPs) in Breast Cancer: A Comprehensive Literature Review and New Data on Prognosis in Breast Cancer Subtypes
Previous Article in Journal
Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer
Previous Article in Special Issue
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
 
 
Review
Peer-Review Record

Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice

Cancers 2022, 14(9), 2102; https://doi.org/10.3390/cancers14092102
by Francesca Carlino 1,2,*, Anna Diana 3, Antonio Piccolo 1, Anna Ventriglia 1, Vincenzo Bruno 1, Irene De Santo 2, Ortensio Letizia 2, Ferdinando De Vita 1, Bruno Daniele 3, Fortunato Ciardiello 1 and Michele Orditura 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Cancers 2022, 14(9), 2102; https://doi.org/10.3390/cancers14092102
Submission received: 17 February 2022 / Revised: 16 April 2022 / Accepted: 19 April 2022 / Published: 23 April 2022
(This article belongs to the Special Issue Triple Negative Breast Cancer: From Biology to Treatment)

Round 1

Reviewer 1 Report

Authors aims to summarize the recent knowledge on BC immune-gram and the 38 biomarkers proposed to support ICIs based therapy in TNBC, and to provide an overview of po-39 tential strategies to enhance immune response and overcome mechanisms of resistance. I enjoyed reading this review and thinks that this will be very helpful for the growing field. I do not have any major objections with this review. Nice work!. Thank you!

Author Response

Dear reviewers,

Thank you for taking the time to review our manuscript.

We are pleased with the positive comments.

The paper has been carefully reviewed for improvement of the English language.

We are sending you the revised manuscript with all the highlighted changes for your review.

We hope you all find them with your satisfaction.

Thanking you in advance, I look forward to hearing from you.

 

Best regards,

Francesca Carlino, on behalf of all authors

Reviewer 2 Report

This is a comprehensive review in the area of immunotherapy for triple negative breast cancer. The subject is timely and important for the readership.

The main question is the mechanism and effectiveness of immunotherapy in triple negative breast cancer. The topic is relevant in the field, but not original as it is a review article and does present already published data. 

Methodology and references are appropriate.

The conclusions are consistent with the evidence and arguments presented and they address the main question posed.

 

Author Response

Dear reviewers,

Thank you for taking the time to review our manuscript.

We are pleased with the positive comments.

The paper has been carefully reviewed for improvement of the English language.

We are sending you the revised manuscript with all the highlighted changes for your review.

We hope you all find them with your satisfaction.

Thanking you in advance, I look forward to hearing from you.

 

Best regards,

Francesca Carlino, on behalf of all authors

Reviewer 3 Report

cancers-1623066-peer-review-v1

General Comments: This is one of the most comprehensive and well-written review papers I have read in some time. Therefore, this was a joy to review. No edits/changes requested.

Author Response

Dear reviewers,

Thank you for taking the time to review our manuscript.

We are pleased with the positive comments.

The paper has been carefully reviewed for improvement of the English language.

We are sending you the revised manuscript with all the highlighted changes for your review.

We hope you all find them with your satisfaction.

Thanking you in advance, I look forward to hearing from you.

 

Best regards,

Francesca Carlino, on behalf of all authors

Back to TopTop